Our aim was to define mechanisms whereby conjugated estrogens (Premarin, exogenous estrogen; Ayerst Laboratories, New York) increase the risk of developing cholesterol gallstones and to determine the role, if any, of dietary cholesterol. We studied gallbladder motor function, biliary lipid composition and secretion, cholesterol absorption, cholesterol synthesis and esterification by peripheral blood mononuclear cells, the clearance of chylomicron remnants, and bile acid kinetics in 29 anovulatory women. 13 were studied on both a low (443±119 jsmol/d) and high (2,021±262 ,umol/d) cholesterol diet. Premarin increased the lithogenic index of bile (P < 0.05), increased biliary cholesterol secretion (P < 0.005), lowered chenodeoxycholate (CDCA) pool (P < 0.001) and synthesis (P < 0.05), altered biliary bile acid composition (ICA + DCAI/ CDCAt, P < 0.005), stimulated cholesterol esterification (P < 0.03), and enhanced the clearance of chylomicron remnants (P = 0.07). Increases in dietary cholesterol stimulated the biliary secretion of cholesterol (P = 0.07), bile acid (P < 0.05), phospholipid (P = 0.07), and as a result, did not alter lithogenic index. The reduction in CDCA pool and synthesis by Premarin was reversed by increasing dietary cholesterol. Off Premarin, only 24% of the increase in cholesterol entering the body in the diet was recovered as biliary cholesterol or newly synthesized bile acid. On Premarin, 68% of this increase in cholesterol was recovered as these biliary lipids. We conclude that Premarin increases biliary cholesterol by enhancing hepatic lipoprotein uptake and inhibiting bile acid synthesis. These actions of Premarin divert dietary cholesterol into bile. (J. Clin. Invest. 1991. 87:237-246.)
Introduction
The risk of developing cholesterol gallstones is increased by pregnancy (1) (2) (3) (4) (5) , contraceptive steroids (6, 7) , and conjugated estrogens (8, 9) . Although the mechanisms whereby female steroid hormones induce gallstones are incompletely defined, previous studies have shown that female steroid hormones significantly alter hepatobiliary physiology. For example, gallbladder volume increases during late pregnancy (10) (11) (12) , and the emptying ofthe gallbladder is slowed by pregnancy, use ofcontraceptive steroids, (10, 13) , or progestin (14) . The cholesterol content of bile is increased in late pregnancy ( 15) and during use ofcontraceptive steroid mixtures (13, 16, 17) , ethinyl estradiol (18, 19) , or a combination of conjugated estrogens and medroxyprogesterone (20) . In addition, bile acid metabolism is altered by pregnancy (15) and contraceptive steroids (13, 17, 21) . Despite these observations, there have been no comprehensive studies of the effects of estrogen, administered alone, on hepatobiliary function.
Studies of the effects of dietary cholesterol on biliary lipid metabolism in humans have given conflicting results. DenBesten et al. (22) and Lee et al. (23) found that increases in dietary cholesterol were associated with increases in the cholesterol saturation ofbile. However, Dam et al. (24) and Anderson and Hellstrom (25) observed no increase in biliary cholesterol with increases in dietary cholesterol. These discrepant results have been attributed to differences in the populations studied and diets used. Increases in dietary cholesterol have been associated with increased absorption of absolute amounts of cholesterol, reduced synthesis of cholesterol, and increased excretion of cholesterol through the biliary tract (26) (27) (28) . There have been no comprehensive studies in healthy people of the effects of dietary cholesterol on hepatic lipid metabolism.
We evaluated the effects of Premarin (exogenous estrogen, Ayerst Laboratories, New York), a commonly prescribed preparation ofconjugated estrogens, on hepatobiliary function during different dietary intakes of cholesterol. We determined whether Premarin or dietary cholesterol altered gallbladder motor function, the lipid composition of gallbladder bile, the secretion of biliary lipids, cholesterol synthesis and esterification by peripheral blood mononuclear cells, the absorption of cholesterol from the intestine, the plasma clearance of chylomicron remnants labeled with retinyl palmitate, and the steady-state kinetics of bile acids.
Methods

Materials
The following materials and equipment were used in these studies: [4- '4C]cholesterol, [1,2- Chemical Co., Phillipsburg, NJ, and Analytichem International, Harbor City, CA2); [24-'3C] cholate, [24- 
Subjects
This study was approved by the Human Subject Committee of the University of Colorado School of Medicine. All subjects (Table I) were paid volunteers and gave written, informed consent. 29 healthy, anovulatory women (aged 28-62 yr) were each studied on or off Premarin for at least 4 wk.3 16 were studied on a diet containing moderate amounts of cholesterol (1,316±262 Amol/d; two studies per subject). 13 subjects were studied on both a low (443±119 ;imol/d) and high (2,021±262 ;imol/d) cholesterol diet (four studies per subject). 25 
Study protocol
The order of Premarin treatment was random, but in the protocol examining the effects of dietary cholesterol, subjects were first studied on the low cholesterol diet. Subjects were on a given diet for at least 4 wk and studied during the last week ofeach study period. The following were determined at each study period: plasma lipids and routine chemistries, gallbladder motor function, cholesterol absorption, cholesterol synthesis and esterification, bile acid kinetics, plasma clearance of retinyl palmitate, and rates of biliary lipid secretion.
Diet
The Clinical Research Center dietician instructed the subjects in diets containing the various amounts ofcholesterol and in the proper maintenance of a daily food diary. The diet and the diary were periodically reviewed by the dietician who calculated the daily cholesterol intake from diet records that were kept throughout the study period (29) .
Procedures
Gallbladder motor function. The volume and contraction of the gallbladder were determined by realtime ultrasonography (30) . Fasting volume (FV) was defined as volume after an overnight fast. Residual volume (RV) was defined as the minimum volume achieved during the 2 h after ingestion of a meal (I 1) or infusion of CCK8 (0.02 jig/kg per h).
The percent offasting volume ejected (%E) and rate constant ofemptying (k) were calculated as described (30) .
Cholesterol absorption and synthesis. This parameter was measured by the dual-isotope ratio method and cholesterol synthesis was determined in peripheral blood mononuclear cells as previously described (16) . The variation between duplicate measurements of cholesterol absorption was 3.8±2.7% and between duplicate measurements of cholesterol synthesis 5.7±5.8%.
Cholesterol esterification. Cholesterol esterification by peripheral blood mononuclear cells was measured by incubation with [2-14C]-2. The packing material of the C8 liquid chromatographic cartridges that were initially used was altered by the manufacturer without notice (J. T. Baker Chemical Co.). The altered C8-bonded phase exhibited completely different chromatographic properties in the extraction and elution ofbile acid methyl esters. As a result, bile acids were not quantitatively recovered during this preparative step in some studies. The poor recoveries contributed to the inability to complete all kinetic analyses. Another C8 cartridge (Analytichem International, Inc.) has demonstrated consistent recoveries for bile acid methyl esters and is currently being used in our laboratory for these assays. 3. Premarin is a mixture of the sulfate esters of estrone (60%), equilin (25%), 17a-dihydroequilin (5-10%), 17a-estradiol, equilenin, and 17a-dihydroequilenin; see Johnson et al. (67) . (16, 32, 33) and lipid secretion rates calculated from marker dilution (34) . Secretion rates were determined from samples obtained at 30-min intervals after initiation of formula infusion (12 samples per 6 h). The coefficients of variation in mean secretion rate were 23%, 24%, and 22% for bile acid, phospholipid, and cholesterol.
Hepatic clearance of chylomicron remnants. The rationale and methods have been described in detail (35) (36) (37) (38) (39) (40) (41) . Retinyl palmitate was given by mouth, and blood was drawn periodically for 24 h (16). Plasma concentrations of retinyl palmitate were measured by HPLC and clearance used as an estimate of the hepatic clearance of chylomicron remnants. Clearance was calculated from the area underneath the plasma concentration curve and was corrected for the mean percent absorption of the administered retinol (96.4%) and for percentage esterified with palmitic acid (71%) (39) .
Bile acid kinetics. A method utilizing stable isotopes and serum sampling was used (42) . Bile acids labeled with stable isotopes (t3C or 2H) were given orally, and blood samples were obtained daily for the subsequent 4-5 d. Bile acids were extracted from serum using C18-liquid chromatographic cartridges. After elution, samples were hydrolyzed with cholylglycine hydrolase, and methylated with dimethoxypropane, methanol, and concentrated HCI. Bile acid methyl esters were further purified using a C8-liquid chromatographic cartridges, and derivatized to their trimethylsilyl ethers. The isotope ratios of chenodeoxycholate (CDCA) and cholate (CA) were determined by selected ion monitoring. The molar ratio of labeled to unlabeled bile acid in each sample (MRJ) was determined from isotope ratios, and fractional turnover rate, pool size, and synthesis were calculated as described (43) . Deoxycholate (DCA) pool was estimated from the same GC/MS runs by comparison ofthe intensity ofits 370 ion to the intensity ofthe 370 ion of CDCA (42) .
Statistical methods. Paired t tests were used to compare the results of the measured variables offand on Premarin. For the analysis ofthe effects of Premarin in all 29 subjects, the results obtained in subjects studied twice, on both a low and high cholesterol diet, were averaged. P values reflect the level ofsignificance for a one-tailed test. The effects of Premarin and dietary cholesterol in the 13 subjects studied during both low and high intake ofdietary cholesterol were evaluated using a 2 X 2 factorial design with multiple paired t tests for three orthogonal contrasts: Premarin, dietary cholesterol, and interaction between Premarin and dietary cholesterol. One-tailed tests were used for the effects of Premarin and dietary cholesterol, but two-tailed tests were used for interactions. The variance about the mean was defined as the standard deviation in all results, tables, figures, and discussion, unless otherwise indicated. Single and multiple linear regression analysis was used to determine the significance of the relationships of the measured variables (44) .
Results
In the sections that follow, all results are presented similarly, the effects of Premarin in all 29 subjects followed by the effects of dietary cholesterol in the subgroup of 13. All measurements were not made in every subject.
Dietary intake ofcholesterol. All subjects maintained adequate dietary records, and use of Premarin (Pr) did not alter cholesterol intake. The mean cholesterol (CH) intake in milligrams per day (± 1 SD) for each study period is given: low CH, off Pr 164±35; low CH, on Pr 175±56; medium CH, off Pr 496±80; medium CH, on Pr 519±120; high CH, off Pr 755±107; high CH, on Pr 805±95.
Gallbladder motorfunction. Lipid composition of gallbladder bile (Fig. 1) . Duodenal bile was obtained after stimulation of gallbladder contraction off and on Premarin in 11, 6, and 12 subjects, on a low, medium, and high cholesterol diet, respectively. Premarin increased the molar percent cholesterol (from 6.95±2.07 to 7.98±2.95, P < 0.04) and the lithogenic index (from 1.11±0.28 to 1.21±0. tion was measured in 10 subjects (Table II) Biliary lipid secretion (Fig. 2) . Secretion studies were completed off and on Premarin in 11, 5, and 9 subjects on a low, medium, and high cholesterol diet, respectively. Premarin increased biliary cholesterol secretion (from 1 4 and Table II) . Cholesterol absorption was unaltered by Premarin (Fig. 4) . However, in 11 subjects increases in dietary cholesterol were associated with a modest decrease in the percent ofcholesterol absorbed (low vs. high cholesterol diet: 51±9 vs. 45±8% off Premarin; 48±11 vs. 44±7% on Premarin, P < 0.025). However, the mean increase in absolute amount of cholesterol absorbed between the low and high diet was 671 grmol/d. also inhibited CDCA synthesis (from 4.4±2.1 to 3.7±1.7, P < 0.05) (Fig. 5) . The fractional turnover rates of both CDCA and CA were unchanged. The effects of dietary cholesterol on bile acid kinetics were determined in nine subjects (Table II) (1) (2) (3) (4) (5) and use of either contraceptive steroids (6, 7) or conjugated estrogens (8, 9) . Use of Premarin, the most commonly prescribed preparation ofconjugated estrogens for postmenopausal women, is associated with twice the risk of developing cholesterol gallstones (8) . For these reasons, we studied the effects of Premarin on human hepatobiliary function. There are several unique features of the present study that deserve special emphasis. We used a paired design to overcome the obstacle ofthe considerable interindividual variation in the various measurements of hepatic lipid metabolism. The number of subjects studied (n = 29) is far greater than that of any other study of the effects of estrogen, administered alone, on hepatic lipid metabolism. A relatively uniform dose ofestrogen was used (1.25 mg/d of Premarin). Most of the processes that regulate cholesterol metabolism were studied in healthy, freeliving subjects. Finally, by studying the effects of Premarin under varying levels of intake of dietary cholesterol, additional insight was gained into the mechanisms of the increase in biliary cholesterol induced by Premarin.
A prerequisite for the formation of cholesterol gallstones is the hepatic secretion of bile that is enriched in cholesterol. In the current study, we found that Premarin significantly increased the biliary secretion ofcholesterol and the lithogenicity of gallbladder bile. Pertsemlidis et al. (20) demonstrated an increase in biliary cholesterol in two women taking a combination of conjugated estrogens plus medroxyprogesterone. In subsequent studies, contraceptive steroids (13, 16, 17, 45) and ethinyl estradiol (18, 19) increased biliary cholesterol. In one study, ethinyl estradiol (46) did not alter biliary cholesterol secretion. The majority of studies support the conclusion that estrogens, given alone or in combination with progestin, stimulate hepatic cholesterol secretion and increase the lithogenicity of bile.
The 18% increase in biliary cholesterol secretion induced by 1.25 mg/d Premarin was modest but similar to the 19% increase caused by low estrogen (30) (31) (32) (33) (34) (35) Mg of ethinyl estradiol) oral contraceptives (16) . In contrast, biliary cholesterol increased 50% during intake ofcontraceptive steroids containing 50 gg of ethinyl estradiol (13, 17 density lipoproteins (LDL) (43) , their effect on the hepatic uptake ofchylomicron remnants is less clear. Remnant clearance is stimulated by estrogen treatment ofrabbits or hypertriglyceridemic subjects and use of contraceptive steroids in women (47) (48) (49) . Because chylomicron remnants can be removed by the LDL receptor (43, 50) , their clearance may reflect the activity ofnot only a "remnant" receptor but also the LDL receptor. In a recent study (51), the hepatic LDL receptor was not required for binding of remnants to hepatic membranes, but was essential for internalization of the remnant. In our previous studies, contraceptive steroids containing 50 1Ag of ethinyl estradiol increased the clearance of chylomicron remnants (48), but contraceptive steroids containing 35 ,g ofethinyl estradiol did not (16) . In the present study, the clearance ofchylomicron remnants tended to increase on Premarin. These data suggest that hepatic lipoprotein receptors may be stimulated by estrogenic activity equivalent to 50 jsg of ethinyl estradiol but only slightly by less estrogen. Alternatively, modest stimulation of lipoprotein receptors (especially the LDL receptor) by lower doses of estrogen may not be detected by the retinyl palmitate method.
Female steroid hormones have been shown to both inhibit (52) and stimulate (53) the activity of the rate-limiting enzyme in cholesterol biosynthesis, 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase. We found that preparations of contraceptive steroids, containing 35 ,g ofethinyl estradiol did not alter cholesterol synthesis by peripheral blood mononuclear cells (16) . In the current study, Premarin did not alter cholesterol synthesis by these cells. Since there have been no studies comparing the effects ofestrogen on cholesterol synthesis by hepatocytes and mononuclear cells, it could be argued that Premarin did alter hepatic cholesterol synthesis but did not influence cholesterol synthesis by the peripheral blood mononuclear cell. However, coordinate regulation of cholesterol synthesis by the liver and peripheral blood mononuclear cells has been shown in type II hyperlipoproteinemia and during cholesterol feeding, starvation, treatment with LDL cholesterol, and treatment with cholestyramine (34, 54, 55) . The failure of Premarin to alter cholesterol synthesis by mononuclear leukocytes may reflect a true lack of effect of estrogen on cholesterol synthesis, the low potency of Premarin, or less likely, differences in the response of various cell types. (59) (60) (61) . In two of these studies, the increase in biliary cholesterol was related to either a decrease in CDCA or increase in CA (59, 60) . In the third, the change in secretion was mainly due to an increase in DCA (61) .
In the present study, the increase in (63) . In an earlier study (16), we found coordinate regulation of cholesterol metabolism during use of contraceptive steroid mixtures of estrogen and progestin. Specifically, as the rate of either cholesterol synthesis or chylomicron remnant uptake increased, there was a significant increase in biliary cholesterol secretion. However, as the contribution of cholesterol synthesis to biliary cholesterol secretion increased, the contribution from chylomicron remnants decreased. We postulated that these effects were due to suppression of ACAT activity by the progestin component of the contraceptive steroid mixture (64) (65) (66) . With ACAT activity inhibited, any cholesterol entering the hepatocyte must leave as either biliary cholesterol, secreted VLDL, or newly synthesized bile acid. In the present study of Premarin, we observed an additive effect of cholesterol synthesis and remnant clearance on biliary cholesterol secretion. This is consistent with the unchanged or increased activity ofACAT during Premarin administration suggesting that cholesterol entering the hepatocyte may be esterified at a rate dependent upon substrate availability. Thus, only when input to the cholesterol pool is increased by stimulation of both cholesterol synthesis and remnant uptake, is there a direct correlation between input and the rate of secretion of biliary cholesterol.
An hypothesis for the effects of estrogen on hepatic lipid metabolism is suggested. Premarin increases biliary cholesterol by three mechanisms. First, Premarin stimulates hepatic lipoprotein receptors, increasing the input of cholesterol to the hepatic free cholesterol pool. Secondly, Premarin inhibits the formation of regulatory oxysterols so that the increased uptake of lipoprotein cholesterol is not associated with reduction of cholesterol synthesis. Thirdly, Premarin inhibits the catabolism of cholesterol to bile acid diminishing a major disposal path for hepatic free cholesterol. As a result, two remaining pathways of disposition of hepatic free cholesterol, biliary secretion of cholesterol and cholesterol esterification, are enhanced to accommodate the increased cholesterol load. Both cholesterol secretion and cholesterol esterification were increased significantly by Premarin. The cholesterol balance data of subjects ingesting various amounts of dietary cholesterol also support this hypothesis. Off Premarin, only 24% ofthe increment in absorbed dietary cholesterol between low and high cholesterol diets was excreted as cholesterol and newly synthesized bile acid. On Premarin, 68% of the increment in absorbed dietary cholesterol was excreted as these biliary sterols. In summary, a major effect of Premarin on total body cholesterol balance is to divert dietary cholesterol into bile and to increase the risk of cholesterol gallstones. This effect might also be regarded as a protective mechanism to decrease cholesterol accumulation in peripheral tissues, such as arterial macrophages.
